Ani Pharmaceuticals (NASDAQ: ANIP) reported Q1 EPS of $0.33, $0.01 better than the analyst estimate of $0.32. Revenue for the quarter came in at $10.9 million versus the consensus estimate of $11.4 million.

For earnings history and earnings-related data on Ani Pharmaceuticals (ANIP) click here.